tiprankstipranks
BridgeBio price target raised to $50 from $45 at Evercore ISI
PremiumThe FlyBridgeBio price target raised to $50 from $45 at Evercore ISI
26d ago
BridgeBio receives positive CHMP opinion for acoramidis for ATTR-CM treatment
Premium
The Fly
BridgeBio receives positive CHMP opinion for acoramidis for ATTR-CM treatment
1M ago
BridgeBio participates in a conference call with Cantor Fitzgerald
Premium
The Fly
BridgeBio participates in a conference call with Cantor Fitzgerald
1M ago
BridgeBio FDA approval ‘significant clearing event,’ says Citi
PremiumThe FlyBridgeBio FDA approval ‘significant clearing event,’ says Citi
2M ago
BridgeBio price target raised to $45 from $42 at BofA
Premium
The Fly
BridgeBio price target raised to $45 from $42 at BofA
2M ago
BridgeBio price target raised to $49 from $43 at H.C. Wainwright
Premium
The Fly
BridgeBio price target raised to $49 from $43 at H.C. Wainwright
2M ago
BridgeBio announces publication of PROPEL 2 data in NEJM
PremiumThe FlyBridgeBio announces publication of PROPEL 2 data in NEJM
2M ago
BridgeBio price target raised to $45 from $44 at Scotiabank
Premium
The Fly
BridgeBio price target raised to $45 from $44 at Scotiabank
2M ago
BridgeBio Pharma Reports Quarterly Loss Amid Restructuring
Premium
Company Announcements
BridgeBio Pharma Reports Quarterly Loss Amid Restructuring
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100